AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD

Running, not enrolling

Conditions studied: Duchenne Muscular Dystrophy

In brief

This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).

Key facts

Study ID

NCT05683379

Run by

REGENXBIO Inc.

People needed

200

Starts

2022-12-20

Expected to finish

2026-09-01

Last updated by the study team

2026-07-07

Who can join

Age: any, up to 25. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males at least 0 to <25 years of age
• Diagnosis of DMD
• Provision of signed and dated informed consent form (ICF) and assent as required per local regulations or requirements

You may not qualify if…

• Prior participation in a gene therapy trial OR recipient of a gene therapy drug
• Other inclusion/exclusion criteria apply

Where it is running

• Rare Disease Research — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.